位置:首页 > 蛋白库 > PNISR_HUMAN
PNISR_HUMAN
ID   PNISR_HUMAN             Reviewed;         805 AA.
AC   Q8TF01; A8K540; E1P5D2; Q5T064; Q5T065; Q6P2B4; Q6P2N4; Q6PJ93; Q6PK36;
AC   Q7Z640; Q8N2L1; Q8TF00; Q96K10; Q96SI3; Q96SM5; Q9P076; Q9P0C0; Q9Y4N3;
DT   05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   10-JUL-2007, sequence version 2.
DT   03-AUG-2022, entry version 153.
DE   RecName: Full=Arginine/serine-rich protein PNISR;
DE   AltName: Full=PNN-interacting serine/arginine-rich protein;
DE   AltName: Full=SR-related protein;
DE   AltName: Full=SR-rich protein;
DE   AltName: Full=Serine/arginine-rich-splicing regulatory protein 130;
DE            Short=SRrp130;
DE   AltName: Full=Splicing factor, arginine/serine-rich 130;
DE   AltName: Full=Splicing factor, arginine/serine-rich 18;
GN   Name=PNISR; Synonyms=C6orf111, SFRS18, SRRP130; ORFNames=HSPC261, HSPC306;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH PNN, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Kidney;
RX   PubMed=14578391; DOI=10.1167/iovs.03-0240;
RA   Zimowska G., Shi J., Munguba G., Jackson M.R., Alpatov R., Simmons M.N.,
RA   Shi Y., Sugrue S.P.;
RT   "Pinin/DRS/memA interacts with SRp75, SRm300 and SRrp130 in corneal
RT   epithelial cells.";
RL   Invest. Ophthalmol. Vis. Sci. 44:4715-4723(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Embryo;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-497 (ISOFORM 1).
RC   TISSUE=Blood, Pancreas, Placenta, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 238-499 AND 661-805.
RC   TISSUE=Umbilical cord blood;
RA   Ye M., Zhang Q.-H., Zhou J., Shen Y., Wu X.-Y., Guan Z.Q., Wang L.,
RA   Fan H.-Y., Mao Y.-F., Dai M., Huang Q.-H., Chen S.-J., Chen Z.;
RT   "Human partial CDS from CD34+ stem cells.";
RL   Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 507-805.
RC   TISSUE=Brain;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-211, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-290, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-211; SER-290; SER-313;
RP   SER-321 AND SER-726, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-204; SER-211; SER-290;
RP   SER-465; SER-467 AND THR-485, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-218, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [16]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-218; LYS-496 AND LYS-703, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- SUBUNIT: Interacts with PNN. {ECO:0000269|PubMed:14578391}.
CC   -!- SUBCELLULAR LOCATION: Nucleus speckle {ECO:0000269|PubMed:14578391}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8TF01-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8TF01-2; Sequence=VSP_014458, VSP_014459;
CC   -!- TISSUE SPECIFICITY: Expressed in heart, skeletal muscle, thymus,
CC       spleen, kidney, liver, placenta and leukocytes.
CC       {ECO:0000269|PubMed:14578391}.
CC   -!- SIMILARITY: Belongs to the splicing factor SR family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH07791.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=AAH19074.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=AAH52638.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=AAH64413.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=AAH64640.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF314184; AAL76163.1; -; mRNA.
DR   EMBL; AF314185; AAL76164.1; -; mRNA.
DR   EMBL; AK027658; BAB55273.1; -; mRNA.
DR   EMBL; AK027759; BAB55350.1; -; mRNA.
DR   EMBL; AK027898; BAB55440.1; -; mRNA.
DR   EMBL; AK074628; BAC11098.1; ALT_TERM; mRNA.
DR   EMBL; AK291155; BAF83844.1; -; mRNA.
DR   EMBL; AL513550; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471051; EAW48476.1; -; Genomic_DNA.
DR   EMBL; CH471051; EAW48477.1; -; Genomic_DNA.
DR   EMBL; CH471051; EAW48479.1; -; Genomic_DNA.
DR   EMBL; CH471051; EAW48481.1; -; Genomic_DNA.
DR   EMBL; BC007791; AAH07791.1; ALT_SEQ; mRNA.
DR   EMBL; BC019074; AAH19074.1; ALT_SEQ; mRNA.
DR   EMBL; BC052638; AAH52638.1; ALT_SEQ; mRNA.
DR   EMBL; BC064413; AAH64413.1; ALT_FRAME; mRNA.
DR   EMBL; BC064640; AAH64640.1; ALT_SEQ; mRNA.
DR   EMBL; AF161379; AAF28939.1; -; mRNA.
DR   EMBL; AF161424; AAF28984.1; -; mRNA.
DR   EMBL; AL080186; CAB45767.1; -; mRNA.
DR   CCDS; CCDS5043.1; -. [Q8TF01-1]
DR   PIR; T12483; T12483.
DR   RefSeq; NP_001309334.1; NM_001322405.1. [Q8TF01-1]
DR   RefSeq; NP_001309335.1; NM_001322406.1. [Q8TF01-1]
DR   RefSeq; NP_001309337.1; NM_001322408.1. [Q8TF01-1]
DR   RefSeq; NP_001309341.1; NM_001322412.1.
DR   RefSeq; NP_001309342.1; NM_001322413.1.
DR   RefSeq; NP_001309344.1; NM_001322415.1.
DR   RefSeq; NP_056306.1; NM_015491.2. [Q8TF01-1]
DR   RefSeq; NP_116259.2; NM_032870.3. [Q8TF01-1]
DR   AlphaFoldDB; Q8TF01; -.
DR   SMR; Q8TF01; -.
DR   BioGRID; 117448; 43.
DR   IntAct; Q8TF01; 19.
DR   MINT; Q8TF01; -.
DR   STRING; 9606.ENSP00000358242; -.
DR   iPTMnet; Q8TF01; -.
DR   PhosphoSitePlus; Q8TF01; -.
DR   BioMuta; PNISR; -.
DR   DMDM; 152031686; -.
DR   EPD; Q8TF01; -.
DR   jPOST; Q8TF01; -.
DR   MassIVE; Q8TF01; -.
DR   MaxQB; Q8TF01; -.
DR   PaxDb; Q8TF01; -.
DR   PeptideAtlas; Q8TF01; -.
DR   PRIDE; Q8TF01; -.
DR   ProteomicsDB; 74530; -. [Q8TF01-1]
DR   ProteomicsDB; 74531; -. [Q8TF01-2]
DR   Antibodypedia; 32003; 33 antibodies from 15 providers.
DR   DNASU; 25957; -.
DR   Ensembl; ENST00000369239.10; ENSP00000358242.5; ENSG00000132424.17. [Q8TF01-1]
DR   Ensembl; ENST00000438806.5; ENSP00000387997.1; ENSG00000132424.17. [Q8TF01-1]
DR   Ensembl; ENST00000647811.1; ENSP00000496842.1; ENSG00000132424.17. [Q8TF01-1]
DR   GeneID; 25957; -.
DR   KEGG; hsa:25957; -.
DR   MANE-Select; ENST00000369239.10; ENSP00000358242.5; NM_032870.4; NP_116259.2.
DR   UCSC; uc003ppo.5; human. [Q8TF01-1]
DR   CTD; 25957; -.
DR   DisGeNET; 25957; -.
DR   GeneCards; PNISR; -.
DR   HGNC; HGNC:21222; PNISR.
DR   HPA; ENSG00000132424; Low tissue specificity.
DR   MIM; 616653; gene.
DR   neXtProt; NX_Q8TF01; -.
DR   OpenTargets; ENSG00000132424; -.
DR   PharmGKB; PA162402984; -.
DR   VEuPathDB; HostDB:ENSG00000132424; -.
DR   eggNOG; ENOG502QUV0; Eukaryota.
DR   GeneTree; ENSGT00730000111138; -.
DR   HOGENOM; CLU_372518_0_0_1; -.
DR   InParanoid; Q8TF01; -.
DR   OMA; RHKHKSE; -.
DR   OrthoDB; 928665at2759; -.
DR   PhylomeDB; Q8TF01; -.
DR   TreeFam; TF332904; -.
DR   PathwayCommons; Q8TF01; -.
DR   SignaLink; Q8TF01; -.
DR   BioGRID-ORCS; 25957; 344 hits in 1100 CRISPR screens.
DR   ChiTaRS; PNISR; human.
DR   GeneWiki; PNISR_(gene); -.
DR   GenomeRNAi; 25957; -.
DR   Pharos; Q8TF01; Tdark.
DR   PRO; PR:Q8TF01; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q8TF01; protein.
DR   Bgee; ENSG00000132424; Expressed in right hemisphere of cerebellum and 201 other tissues.
DR   ExpressionAtlas; Q8TF01; baseline and differential.
DR   Genevisible; Q8TF01; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0048786; C:presynaptic active zone; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   InterPro; IPR031937; PNISR.
DR   PANTHER; PTHR31518; PTHR31518; 2.
DR   Pfam; PF15996; PNISR; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Isopeptide bond; Nucleus;
KW   Phosphoprotein; Reference proteome; Ubl conjugation.
FT   CHAIN           1..805
FT                   /note="Arginine/serine-rich protein PNISR"
FT                   /id="PRO_0000081947"
FT   REGION          74..331
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          382..805
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          237..276
FT                   /evidence="ECO:0000255"
FT   COILED          429..461
FT                   /evidence="ECO:0000255"
FT   COILED          673..703
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        74..92
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        97..119
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        122..151
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        179..198
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        231..290
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        302..316
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        395..460
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        474..508
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        509..548
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        549..576
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        577..610
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        611..635
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        636..721
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        730..756
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        791..805
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         204
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         211
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163"
FT   MOD_RES         290
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163"
FT   MOD_RES         304
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:A2AJT4"
FT   MOD_RES         313
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   MOD_RES         321
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   MOD_RES         465
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         467
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         485
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         726
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   CROSSLNK        218
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:25218447,
FT                   ECO:0007744|PubMed:28112733"
FT   CROSSLNK        496
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        703
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         368..413
FT                   /note="APAKQLAQSSALASLTGLGGLGGYGSGDSEDERSDRGSESSDTDDE -> GI
FT                   FWCFWFCFSWGILVLMTILAFFCCPCWISTRYLNILLHVLTLKD (in isoform
FT                   2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_014458"
FT   VAR_SEQ         414..805
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_014459"
FT   CONFLICT        34
FT                   /note="W -> R (in Ref. 2; BAB55350)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        249
FT                   /note="K -> R (in Ref. 2; BAB55440)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        327
FT                   /note="E -> G (in Ref. 2; BAB55273)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        507
FT                   /note="R -> G (in Ref. 7; CAB45767)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        518
FT                   /note="S -> P (in Ref. 1; AAL76163)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        663
FT                   /note="Q -> R (in Ref. 7; CAB45767)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        784
FT                   /note="V -> A (in Ref. 1; AAL76163/AAL76164)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        805
FT                   /note="R -> KSSILFKVFCLIFKKN (in Ref. 6; AAF28939)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   805 AA;  92577 MW;  7738BC276B6E80B2 CRC64;
     MWDQGGQPWQ QWPLNQQQWM QSFQHQQDPS QIDWAALAQA WIAQREASGQ QSMVEQPPGM
     MPNGQDMSTM ESGPNNHGNF QGDSNFNRMW QPEWGMHQQP PHPPPDQPWM PPTPGPMDIV
     PPSEDSNSQD SGEFAPDNRH IFNQNNHNFG GPPDNFAVGP VNQFDYQHGA AFGPPQGGFH
     PPYWQPGPPG PPAPPQNRRE RPSSFRDRQR SPIALPVKQE PPQIDAVKRR TLPAWIREGL
     EKMEREKQKK LEKERMEQQR SQLSKKEKKA TEDAEGGDGP RLPQRSKFDS DEEEEDTENV
     EAASSGKVTR SPSPVPQEEH SDPEMTEEEK EYQMMLLTKM LLTEILLDVT DEEIYYVAKD
     AHRKATKAPA KQLAQSSALA SLTGLGGLGG YGSGDSEDER SDRGSESSDT DDEELRHRIR
     QKQEAFWRKE KEQQLLHDKQ MEEEKQQTER VTKEMNEFIH KEQNSLSLLE AREADGDVVN
     EKKRTPNETT SVLEPKKEHK EKEKQGRSRS GSSSSGSSSS NSRTSSTSST VSSSSYSSSS
     GSSRTSSRSS SPKRKKRHSR SRSPTIKARR SRSRSYSRRI KIESNRARVK IRDRRRSNRN
     SIERERRRNR SPSRERRRSR SRSRDRRTNR ASRSRSRDRR KIDDQRGNLS GNSHKHKGEA
     KEQERKKERS RSIDKDRKKK DKEREREQDK RKEKQKREEK DFKFSSQDDR LKRKRESERT
     FSRSGSISVK IIRHDSRQDS KKSTTKDSKK HSGSDSSGRS SSESPGSSKE KKAKKPKHSR
     SRSVEKSQRS GKKASRKHKS KSRSR
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024